Table of Contents Author Guidelines Submit a Manuscript
Cardiovascular Therapeutics
Volume 2019, Article ID 9546931, 12 pages
https://doi.org/10.1155/2019/9546931
Review Article

Sex-Specific Cut-Offs for High-Sensitivity Cardiac Troponin: Is Less More?

1Department of Internal Medicine and Medical Specialties, Sapienza–University of Rome, Rome, Italy
2Division of Cardiology, San Paolo Hospital, Department of Health Sciences, University of Milan, Milan, Italy
3Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy
4Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza–University of Rome, Rome, Italy
5Department of Movement, Human and Health Sciences, University of Rome “Foro Italico”, Rome, Italy
6Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
7Department of Experimental Medicine, Sapienza–University of Rome, Rome, Italy
8Center for Outcomes Research and Evaluation, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada

Correspondence should be addressed to Stefania Basili; ti.1amorinu@ilisab.ainafets

Received 14 October 2018; Revised 8 January 2019; Accepted 16 January 2019; Published 5 February 2019

Academic Editor: Nicholas B. Norgard

Copyright © 2019 Giulio Francesco Romiti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Goodacre, “The health care burden of acute chest pain,” Heart, vol. 91, no. 2, pp. 229-230, 2005. View at Publisher · View at Google Scholar
  2. A. K. Venkatesh, Y. Dai, J. S. Ross, J. D. Schuur, R. Capp, and H. M. Krumholz, “Variation in US hospital emergency department admission rates by clinical condition,” Medical Care, vol. 53, no. 3, pp. 237–244, 2015. View at Publisher · View at Google Scholar
  3. D. C. Knockaert, F. Buntinx, N. Stoens, R. Bruyninckx, and H. Delooz, “Chest pain in the emergency department: The broad spectrum of causes,” European Journal of Emergency Medicine, vol. 9, no. 1, pp. 25–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Haasenritter, T. Biroga, C. Keunecke et al., “Causes of chest pain in primary care – a systematic review and meta-analysis,” Croatian Medical Journal, vol. 56, no. 5, pp. 422–430, 2015. View at Publisher · View at Google Scholar
  5. N. D. Thang, B. W. Karlson, B. Bergman et al., “Patients admitted to hospital with chest pain — Changes in a 20-year perspective,” International Journal of Cardiology, vol. 166, no. 1, pp. 141–146, 2013. View at Publisher · View at Google Scholar
  6. M. C. Kontos, D. B. Diercks, and J. D. Kirk, “Emergency department and office-based evaluation of patients with chest pain,” Mayo Clinic Proceedings, vol. 85, no. 3, pp. 284–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Kolansky, “Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden,” American Journal of Managed Care, vol. 15, no. 2, pp. S36–S41, 2009. View at Google Scholar · View at Scopus
  8. F. Sanchis-Gomar, C. Perez-Quilis, R. Leischik, and A. Lucia, “Epidemiology of coronary heart disease and acute coronary syndrome,” Annals of Translational Medicine, vol. 4, no. 13, pp. 256–256, 2016. View at Publisher · View at Google Scholar
  9. M. Roffi, C. Patrono, J.-P. Collet, C. Mueller, M. Valgimigli, F. Andreotti et al., “2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation,” European Heart Journal, vol. 37, pp. 267–315, 2016. View at Publisher · View at Google Scholar
  10. P. G. Steg, S. K. James, D. Atar et al., “ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation,” European Heart Journal, vol. 33, no. 20, pp. 2569–2619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Thygesen, J. Mair, H. Katus et al., “Recommendations for the use of cardiac troponin measurement in acute cardiac care,” European Heart Journal, vol. 31, no. 18, pp. 2197–2204, 2010. View at Publisher · View at Google Scholar
  12. K. Thygesen, J. S. Alpert, A. S. Jaffe et al., “Fourth universal definition of myocardial infarction (2018),” European Heart Journal, vol. 60, pp. 1581–1598, 2018. View at Publisher · View at Google Scholar
  13. N. Bandstein, R. Ljung, M. Johansson, and M. J. Holzmann, “Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction,” Journal of the American College of Cardiology, vol. 63, no. 23, pp. 2569–2578, 2014. View at Publisher · View at Google Scholar
  14. K. Yahagi, H. R. Davis, E. Arbustini, and R. Virmani, “Sex differences in coronary artery disease: pathological observations,” Atherosclerosis, vol. 239, no. 1, pp. 260–267, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Wong, K. M. Rexrode, R. K. Sandhu, M. V. Moorthy, D. Conen, and C. M. Albert, “Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation,” Heart, vol. 103, 2017. View at Publisher · View at Google Scholar
  16. M. S. Parmacek and R. Solaro, “Biology of the troponin complex in cardiac myocytes,” Progress in Cardiovascular Diseases, vol. 47, no. 3, pp. 159–176, 2004. View at Publisher · View at Google Scholar
  17. H. A. Katus, A. Remppis, T. Scheffold, K. W. Diederich, and W. Kuebler, “Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction,” American Journal of Cardiology, vol. 67, no. 16, pp. 1360–1367, 1991. View at Publisher · View at Google Scholar
  18. M. A. Daubert and A. Jeremias, “The utility of troponin measurement to detect myocardial infarction: review of the current findings,” Vascular Health and Risk Management, vol. 6, pp. 691–699, 2010. View at Publisher · View at Google Scholar
  19. M. W. Sherwood and L. Kristin Newby, “High‐sensitivity troponin assays: Evidence, indications, and reasonable use,” Journal of the American Heart Association, vol. 3, no. 1, Article ID e000403, 2014. View at Publisher · View at Google Scholar
  20. A. S. Shah, A. Anand, Y. Sandoval et al., “High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study,” The Lancet, vol. 386, pp. 2481–2488, 2015. View at Publisher · View at Google Scholar
  21. M. Westwood, T. van Asselt, B. Ramaekers et al., “High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis,” Health Technology Assessment, vol. 19, no. 44, pp. 1–234, 2015. View at Publisher · View at Google Scholar
  22. P. K. Myint, C. S. Kwok, M. O. Bachmann, S. Stirling, L. Shepstone, and M. J. Zaman, “Prognostic value of troponins in acute coronary syndrome depends upon patient age,” Heart, vol. 100, no. 20, pp. 1583–1590, 2014. View at Publisher · View at Google Scholar
  23. M. Mueller, M. Biener, M. Vafaie et al., “Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome,” Clinical Chemistry, vol. 58, no. 1, pp. 209–218, 2011. View at Publisher · View at Google Scholar
  24. T. Keller, T. Zeller, F. Ojeda et al., “Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction,” Journal of the American Medical Association, vol. 306, no. 24, p. 2684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Reichlin, A. Irfan, R. Twerenbold et al., “Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction,” Circulation, vol. 124, no. 2, pp. 136–145, 2011. View at Publisher · View at Google Scholar
  26. L. Y. Fan, P. Yu, S. S. Yu et al., “Age-specific 99th percentile cutoff of high-sensitivity cardiac troponin T for early prediction of non-st-segment elevation myocardial infarction (NSTEMI) in middle-aged patients,” Journal of Clinical Laboratory Analysis, vol. 28, no. 1, pp. 10–15, 2014. View at Publisher · View at Google Scholar
  27. M. Krintus, M. Kozinski, P. Boudry et al., “Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I,” International Journal of Cardiology, vol. 187, pp. 256–263, 2015. View at Publisher · View at Google Scholar
  28. E. P. Cardinaels, A. M. Mingels, L. H. Jacobs, S. J. Meex, O. Bekers, and M. P. van Dieijen-Visser, “A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 5, pp. 791–806, 2012. View at Publisher · View at Google Scholar
  29. F. S. Apple, P. O. Collinson, and IFCC Task Force on Clinical Applications of Cardiac Biomarkers, “Analytical characteristics of high-sensitivity cardiac troponin assays,” Clinical Chemistry, vol. 58, no. 1, pp. 54–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Thygesen, J. Mair, E. Giannitsis et al., “How to use high-sensitivity cardiac troponins in acute cardiac care,” European Heart Journal, vol. 33, no. 18, pp. 2252–2257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Clerico and G. Lippi, “The state-of-the-art of “high-sensitivity” immunoassay for measuring cardiac troponin I and T,” Journal of Laboratory and Precision Medicine, vol. 3, p. 53, 2018. View at Publisher · View at Google Scholar
  32. A. H. Wu, R. H. Christenson, D. N. Greene et al., “Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: Expert opinion from the academy of the american association for clinical chemistry and the task force on clinical applications of cardiac bio-markers of the international federation of clinical chemistry and laboratory medicine,” Clinical Chemistry, vol. 64, no. 4, pp. 645–655, 2018. View at Publisher · View at Google Scholar
  33. F. S. Apple, A. S. Jaffe, P. Collinson et al., “IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays,” Clinical Biochemistry, vol. 48, pp. 201–203, 2015. View at Publisher · View at Google Scholar
  34. I. Marzona, M. Proietti, A. Farcomeni et al., “Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients,” International Journal of Cardiology, vol. 269, pp. 182–191, 2018. View at Publisher · View at Google Scholar
  35. L. B. Daniels and A. S. Maisel, “Cardiovascular biomarkers and sex: the case for women,” Nature Reviews Cardiology, vol. 12, no. 10, pp. 588–596, 2015. View at Publisher · View at Google Scholar
  36. I. Raymond, B. A. Groenning, P. R. Hildebrandt, J. C. Nilsson, M. Baumann, J. Trawinski et al., “The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population,” Heart, vol. 89, no. 7, pp. 745–751, 2003. View at Publisher · View at Google Scholar
  37. M. Hamada, Y. Shigematsu, M. Takezaki, S. Ikeda, and A. Ogimoto, “Plasma levels of atrial and brain natriuretic peptides in apparently healthy subjects: Effects of sex, age, and hemoglobin concentration,” International Journal of Cardiology, vol. 228, pp. 599–604, 2017. View at Publisher · View at Google Scholar
  38. F. Franconi and I. Campesi, “Sex impact on biomarkers, pharmacokinetics and pharmacodynamics,” Current Medicinal Chemistry, vol. 24, no. 24, 2017. View at Publisher · View at Google Scholar
  39. J. E. Manson and S. S. Bassuk, “Biomarkers of cardiovascular disease risk in women,” Metabolism, vol. 64, no. 3, supplement 1, pp. S33–S39, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. P. O. Collinson, Y. M. Heung, D. Gaze et al., “Influence of population selection on the 99th percentile reference value for cardiac troponin assays,” Clinical Chemistry, vol. 58, no. 1, pp. 219–225, 2012. View at Publisher · View at Google Scholar
  41. F. S. Apple, P. A. Simpson, and M. M. Murakami, “Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay,” Clinical Biochemistry, vol. 43, no. 12, pp. 1034–1036, 2010. View at Publisher · View at Google Scholar
  42. P. M. McKie, D. M. Heublein, C. G. Scott et al., “Defining high-sensitivity cardiac troponin concentrations in the community,” Clinical Chemistry, vol. 59, no. 7, pp. 1099–1107, 2013. View at Publisher · View at Google Scholar
  43. Z. Kong, J. Nie, H. Lin et al., “Sex differences in release of cardiac troponin T after endurance exercise,” Biomarkers, vol. 22, pp. 345–350, 2016. View at Publisher · View at Google Scholar
  44. M. O. Gore, S. L. Seliger, C. R. deFilippi et al., “Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay,” Journal of the American College of Cardiology, vol. 63, no. 14, pp. 1441–1448, 2014. View at Publisher · View at Google Scholar
  45. F. S. Apple and A. S. Jaffe, “Men are different than women: It's true for cardiac troponin too,” Clinical Biochemistry, vol. 47, no. 10-11, pp. 867-868, 2014. View at Publisher · View at Google Scholar
  46. A. Slagman, J. Searle, J. O. Vollert et al., “Sex differences of troponin test performance in chest pain patients,” International Journal of Cardiology, vol. 187, pp. 246–251, 2015. View at Publisher · View at Google Scholar
  47. L. A. Cullen and N. L. Mills, “Point: The use of sex-specific cutpoints for high-sensitivity cardiac troponin assays,” Clinical Chemistry, vol. 63, no. 1, pp. 261–263, 2016. View at Publisher · View at Google Scholar
  48. F. S. Apple, H. E. Quist, P. J. Doyle, A. P. Otto, and M. M. Murakami, “Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations,” Clinical Chemistry, vol. 49, no. 8, pp. 1331–1336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. F. S. Apple, M. Panteghini, J. Ravkilde, J. Mair, A. H. B. Wu, J. Tate et al., “Quality specifications for B-type natriuretic peptide assays,” Clinical Chemistry, vol. 51, no. 3, pp. 486–493, 2005. View at Publisher · View at Google Scholar
  50. M. M. Redfield, R. J. Rodeheffer, S. J. Jacobsen, D. W. Mahoney, K. R. Bailey, and J. C. Burnett Jr., “Plasma brain natriuretic peptide concentration: impact of age and gender,” Journal of the American College of Cardiology, vol. 40, no. 5, pp. 976–982, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. T. J. Wang, M. G. Larson, D. Levy et al., “Impact of age and sex on plasma natriuretic peptide levels in healthy adults,” American Journal of Cardiology, vol. 90, no. 3, pp. 254–258, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. T. J. Wang, M. G. Larson, D. Levy et al., “Plasma natriuretic peptide levels and the risk of cardiovascular events and death,” The New England Journal of Medicine, vol. 350, no. 7, pp. 655–663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Luchner, G. Behrens, J. Stritzke et al., “Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors,” European Journal of Heart Failure, vol. 15, no. 8, pp. 859–867, 2013. View at Publisher · View at Google Scholar
  54. E. Hallengren, P. Almgren, G. Engström et al., “Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality,” Journal of the American College of Cardiology, vol. 64, no. 14, pp. 1452–1460, 2014. View at Publisher · View at Google Scholar
  55. J. E. Ho, C. Liu, A. Lyass et al., “Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community,” Journal of the American College of Cardiology, vol. 60, no. 14, pp. 1249–1256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. L. B. Daniels, P. Clopton, G. A. Laughlin, A. S. Maisel, and E. Barrett-Connor, “Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study,” American Heart Journal, vol. 167, no. 5, pp. 674–682.e1, 2014. View at Publisher · View at Google Scholar
  57. B. Dieplinger, M. Egger, W. Poelz, C. Gabriel, M. Haltmayer, and T. Mueller, “Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females,” Clinical Chemistry and Laboratory Medicine, vol. 49, no. 9, pp. 1515–1518, 2011. View at Publisher · View at Google Scholar
  58. E. E. Coglianese, M. G. Larson, R. S. Vasan et al., “Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the framingham heart study,” Clinical Chemistry, vol. 58, no. 12, pp. 1673–1681, 2012. View at Publisher · View at Google Scholar
  59. O. Melander, M. Belting, J. Manjer et al., “Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer,” Cancer Epidemiology Biomarkers & Prevention, vol. 23, no. 8, pp. 1672–1676, 2014. View at Publisher · View at Google Scholar
  60. O. Melander, A. S. Maisel, P. Almgren et al., “Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality,” Journal of the American Medical Association, vol. 308, no. 14, p. 1469, 2012. View at Publisher · View at Google Scholar
  61. F. S. Apple, R. Ler, and M. M. Murakami, “Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population,” Clinical Chemistry, vol. 58, no. 11, pp. 1574–1581, 2012. View at Publisher · View at Google Scholar
  62. E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A. S. Jaffe, and H. A. Katus, “Analytical validation of a high-sensitivity cardiac troponin T assay,” Clinical Chemistry, vol. 56, no. 2, pp. 254–261, 2010. View at Publisher · View at Google Scholar
  63. G. Koerbin, J. Tate, J. M. Potter, J. Cavanaugh, N. Glasgow, and P. E. Hickman, “Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 5, pp. 871–878, 2012. View at Publisher · View at Google Scholar
  64. J. C. Schwarzenberger, L. S. Sun, M. A. Pesce et al., “Sex-based differences in serum cardiac troponin I, a specific marker for myocardial injury, after cardiac surgery,” Critical Care Medicine, vol. 31, no. 3, pp. 689–693, 2003. View at Publisher · View at Google Scholar
  65. C. J. Salton, M. L. Chuang, C. J. O’Donnell et al., “Gender differences and normal left ventricular anatomy in an adult population free of hypertension,” Journal of the American College of Cardiology, vol. 39, no. 6, pp. 1055–1060, 2002. View at Publisher · View at Google Scholar
  66. R. Fernández-Jiménez, P. López-Romero, A. Suárez-Barrientos et al., “Troponin release overestimates infarct size in presence of left ventricular hypertrophy,” Journal of the American College of Cardiology, vol. 60, no. 7, pp. 640-641, 2012. View at Publisher · View at Google Scholar
  67. M. Piro, R. Della Bona, A. Abbate, L. M. Biasucci, and F. Crea, “Sex-related differences in myocardial remodeling,” Journal of the American College of Cardiology, vol. 55, no. 11, pp. 1057–1065, 2010. View at Publisher · View at Google Scholar
  68. H. D. White, “Pathobiology of Troponin Elevations: Do editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology,” Journal of the American College of Cardiology, vol. 57, no. 24, pp. 2406–2408, 2011. View at Publisher · View at Google Scholar
  69. B. Ostadal, I. Netuka, J. Maly, J. Besik, and I. Ostadalova, “Gender differences in cardiac ischemic injury and protection—experimental aspects,” Experimental Biology and Medicine, vol. 234, no. 9, pp. 1011–1019, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Ostadal and P. Ostadal, “Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications,” British Journal of Pharmacology, vol. 171, no. 3, pp. 541–554, 2014. View at Publisher · View at Google Scholar
  71. V. Raparelli, M. Elharram, A. Shimony, M. J. Eisenberg, A. N. Cheema, and L. Pilote, “Myocardial infarction with no obstructive coronary artery disease: Angiographic and clinical insights in patients with premature presentation,” Canadian Journal of Cardiology, vol. 34, no. 4, pp. 468–476, 2018. View at Publisher · View at Google Scholar
  72. M. E. Mendelsohn and R. H. Karas, “The protective effects of estrogen on the cardiovascular system,” The New England Journal of Medicine, vol. 340, no. 23, pp. 1801–1811, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Sribhen, S. Piyophirapong, and N. Wannasilp, “Cardiac troponin T concentrations in healthy adolescents,” Clinica Chimica Acta, vol. 411, pp. 1542-1543, 2010. View at Publisher · View at Google Scholar
  74. R. Cangemi, G. F. Romiti, G. Campolongo et al., “Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate,” Pharmacological Research, vol. 117, pp. 148–155, 2017. View at Publisher · View at Google Scholar
  75. A. Saenger, R. Beyrau, S. Braun et al., “Multicenter analytical evaluation of a high-sensitivity troponin T assay,” Clinica Chimica Acta, vol. 412, pp. 748–754, 2011. View at Publisher · View at Google Scholar
  76. M. Franzini, V. Lorenzoni, S. Masotti et al., “The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy,” Clinica Chimica Acta, vol. 438, pp. 376–381, 2015. View at Publisher · View at Google Scholar
  77. A. Mingels, L. Jacobs, E. Michielsen, J. Swaanenburg, W. Wodzig, and M. van Dieijen-Visser, “Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays,” Clinical Chemistry, vol. 55, no. 1, pp. 101–108, 2008. View at Publisher · View at Google Scholar
  78. D. M. Kimenai, R. M. Henry, C. J. van der Kallen et al., “Direct comparison of clinical decision limits for cardiac troponin T and I,” Heart, vol. 102, no. 8, pp. 610–616, 2016. View at Publisher · View at Google Scholar
  79. G. Koerbin, J. R. Tate, and P. E. Hickman, “Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population,” Annals of Clinical Biochemistry, vol. 47, no. 6, pp. 524–528, 2010. View at Publisher · View at Google Scholar
  80. T. Mueller, M. Egger, I. Leitner, C. Gabriel, M. Haltmayer, and B. Dieplinger, “Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors,” Clinica Chimica Acta, vol. 456, pp. 19–23, 2016. View at Publisher · View at Google Scholar
  81. J. P. Ungerer, J. R. Tate, and C. J. Pretorius, “Discordance with 3 cardiac troponin I and T assays: Implications for the 99th percentile cutoff,” Clinical Chemistry, vol. 62, no. 8, pp. 1106–1114, 2016. View at Publisher · View at Google Scholar
  82. W. F. Peacock, B. M. Baumann, D. Bruton et al., “Efficacy of high-sensitivity troponin T in identifying very-low-risk patients with possible acute coronary syndrome,” JAMA Cardiology, vol. 3, no. 2, pp. 104–112, 2018. View at Publisher · View at Google Scholar
  83. G. Koerbin, W. P. Abhayaratna, J. M. Potter et al., “Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays,” Clinical Biochemistry, vol. 46, pp. 1636–1643, 2013. View at Publisher · View at Google Scholar
  84. F. S. Apple, Y. Sandoval, A. S. Jaffe, and J. Ordonez-Llanos, “Cardiac troponin assays: Guide to understanding analytical characteristics and their impact on clinical care,” Clinical Chemistry, vol. 63, no. 1, pp. 73–81, 2016. View at Publisher · View at Google Scholar
  85. T. Aw, S. Phua, and S. Tan, “Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender,” Clinica Chimica Acta, vol. 422, pp. 26–28, 2013. View at Publisher · View at Google Scholar
  86. T. Omland, J. A. de Lemos, O. L. Holmen et al., “Impact of sex on the prognostic value of high-sensitivity cardiac troponin i in the general population: The hunt study,” Clinical Chemistry, vol. 61, no. 4, pp. 646–656, 2015. View at Publisher · View at Google Scholar
  87. T. Zeller, F. Ojeda, F. J. Brunner et al., “High-sensitivity cardiac troponin I in the general population – defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study,” Clinical Chemistry and Laboratory Medicine (CCLM), vol. 53, no. 5, pp. 699–706, 2015. View at Publisher · View at Google Scholar
  88. M. Ji, H. Moon, M. Hur, and Y. Yun, “Determination of high-sensitivity cardiac troponin I 99th percentile upper reference limits in a healthy Korean population,” Clinical Biochemistry, vol. 49, pp. 756–761, 2016. View at Publisher · View at Google Scholar
  89. S. Li, Y. Zuo, and W. Huang, “Establishment of a reference interval for high-sensitivity cardiac troponin I in healthy adults from the Sichuan area,” Medicine, vol. 96, no. 14, p. e6252, 2017. View at Publisher · View at Google Scholar
  90. M. Bossard, S. Thériault, S. Aeschbacher et al., “Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population,” Clinical Research in Cardiology, vol. 106, no. 2, pp. 96–104, 2017. View at Publisher · View at Google Scholar
  91. M. Rubini Giménez, R. Twerenbold, J. Boeddinghaus et al., “Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin t in suspected myocardial infarction,” JAMA Cardiology, vol. 1, no. 8, p. 912, 2016. View at Publisher · View at Google Scholar
  92. M. Mueller-Hennessen, B. Lindahl, E. Giannitsis et al., “Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T — Sub-analysis from the TRAPID-AMI study,” International Journal of Cardiology, vol. 209, pp. 26–33, 2016. View at Publisher · View at Google Scholar
  93. K. M. Eggers, T. Jernberg, and B. Lindahl, “Prognostic importance of sex-specific cardiac troponin t 99th percentiles in suspected acute coronary syndrome,” American Journal of Medicine, vol. 129, no. 8, pp. 880.e1–880.e12, 2016. View at Publisher · View at Google Scholar
  94. A. McRae, M. Graham, T. Abedin et al., “Sex-specific, high-sensitivity cardiac troponin T cut-off concentrations for ruling out acute myocardial infarction with a single measurement,” CJEM, pp. 1–8, 2018. View at Publisher · View at Google Scholar
  95. S. Yang, W. Huai, R. Qiao et al., “Age and gender tailored cutoff value of hs-ctnt contributes to rapidly diagnose acute myocardial infarction in chest pain patients,” Clinical Laboratory, vol. 62, pp. 1451–1459, 2016. View at Publisher · View at Google Scholar
  96. A. S. Shah, A. Anand, F. E. Strachan et al., “High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial,” The Lancet, vol. 392, no. 10151, pp. 919–928, 2018. View at Publisher · View at Google Scholar
  97. L. Cullen, J. H. Greenslade, E. W. Carlton et al., “Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain,” Heart, vol. 102, no. 2, pp. 120–126, 2016. View at Publisher · View at Google Scholar
  98. A. S. Shah, M. Griffiths, K. K. Lee et al., “High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study,” BMJ, vol. 350, p. g7873, 2015. View at Publisher · View at Google Scholar
  99. T. Mueller, M. Egger, E. Peer, and B. Dieplinger, “5th generation cardiac troponin I and T assays in clinical routine – A head-to-head comparison with data from the Linz troponin (LITROP) study,” Clinica Chimica Acta, vol. 485, pp. 195–204, 2018. View at Publisher · View at Google Scholar
  100. K. M. Eggers, N. Johnston, S. James, B. Lindahl, and P. Venge, “Cardiac troponin I levels in patients with non–ST-elevation acute coronary syndrome—The importance of gender,” American Heart Journal, vol. 168, no. 3, pp. 317–324.e1, 2014. View at Publisher · View at Google Scholar
  101. E. A. B. May, M. P. Bonaca, P. Jarolim et al., “Prognostic performance of a high-sensitivity cardiac troponin i assay in patients with Non-ST-Elevation acute coronary syndrome,” Clinical Chemistry, vol. 60, no. 1, pp. 158–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. B. Moehring, M. Mueller, M. Rubini Gimenez et al., “Impact of gender-specific reference values of high-sensitivity troponin T on the prevalence and long-term outcome of acute myocardial infarction,” European Heart Journal, vol. 34, no. suppl 1, pp. P4042–P4042, 2013. View at Publisher · View at Google Scholar
  103. A. Clerico, M. Zaninotto, A. Ripoli et al., “The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications,” Clinical Chemistry and Laboratory Medicine (CCLM), vol. 55, no. 11, pp. 1634–1651, 2017. View at Publisher · View at Google Scholar
  104. G. Cediel, M. Gonzalez-del-Hoyo, A. Carrasquer, R. Sanchez, C. Boqué, and A. Bardají, “Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury,” Heart, vol. 103, no. 8, pp. 616–622, 2017. View at Publisher · View at Google Scholar
  105. G. Y. Stein, G. Herscovici, R. Korenfeld et al., “Type-II myocardial infarction – patient characteristics, management and outcomes,” PLoS ONE, vol. 9, no. 1, p. e84285, 2014. View at Publisher · View at Google Scholar
  106. C. J. Pepine, K. C. Ferdinand, L. J. Shaw et al., “Emergence of nonobstructive coronary artery disease,” Journal of the American College of Cardiology, vol. 66, no. 17, pp. 1918–1933, 2015. View at Publisher · View at Google Scholar
  107. D. Monneret, M. Gellerstedt, and D. Bonnefont-Rousselot, “Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach,” Clinical Chemistry and Laboratory Medicine (CCLM), vol. 56, no. 5, pp. 818–829, 2018. View at Publisher · View at Google Scholar
  108. P. Welsh, D. Preiss, A. S. Shah et al., “Comparison between high-sensitivity cardiac troponin t and cardiac troponin i in a large general population cohort,” Clinical Chemistry, vol. 64, no. 11, pp. 1607–1616, 2018. View at Publisher · View at Google Scholar